Institutional Fund
Sphera Funds Management Ltd.
Tel Aviv, IsraelCIK 14962015 filings on record
Portfolio Value
$581.48M
Q1 2026
Holdings
92
Reported positions
New Buys
20
Opened this quarter
QoQ Change
+21.5%
from $478.53M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Mineralys Therapeutics Inc6.2%
- Teva Pharmaceutical Inds Ltd5.9%
- Tower Semiconductor Ltd4.4%
- Nova Ltd4.0%
- Bridgebio Pharma Inc3.1%
- Biogen Inc2.9%
- Other73.4%
Portfolio Holdings
92 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Mineralys Therapeutics Inc | 1.34M | $36.30M | 6.2% | +891.0K | Added |
| 2 | Teva Pharmaceutical Inds Ltd | 1.14M | $34.25M | 5.9% | +13.4K | Added |
| 3 | Tower Semiconductor Ltd | 145.7K | $25.57M | 4.4% | +23.2K | Added |
| 4 | Nova Ltd | 53.4K | $23.18M | 4.0% | +5.5K | Added |
| 5 | Bridgebio Pharma Inc | 245.2K | $18.21M | 3.1% | +137.5K | Added |
| 6 | Biogen Inc | 92.5K | $16.96M | 2.9% | −2.2K | Reduced |
| 7 | Ultragenyx Pharmaceutical In | 809.3K | $16.96M | 2.9% | +508.7K | Added |
| 8 | Syndax Pharmaceuticals Inc | 724.6K | $16.93M | 2.9% | −38.0K | Reduced |
| 9 | Cogent Biosciences Inc | 416.3K | $16.02M | 2.8% | +37.8K | Added |
| 10 | Sanofi SA | 269.5K | $12.99M | 2.2% | +30.0K | Added |
82 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio